The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Brain monoamine oxidase A inhibition in cigarette smokers
Open accessAbstract
Several studies have documented a strong association between smoking and depression. Because cigarette smoke has been reported to inhibit monoamine oxidase (MAO) A in vitro and in animals and because MAO A inhibitors are effective antidepressants, we tested the hypothesis that MAO A would be reduced in the brain of cigarette smokers. We compared brain MAO A in 15 nonsmokers and 16 current smokers with [ 11 C]clorgyline and positron emission tomography (PET). Four of the nonsmokers were also treated with the antidepressant MAO inhibitor drug, tranylcypromine (10 mg/day for 3 days) after the baseline PET scan and then rescanned to assess the sensitivity of [ 11 C]clorgyline binding to MAO inhibition. MAO A levels were quantified by using the model term λk 3 which is a function of brain MAO A concentration. Smokers had significantly lower brain MAO A than nonsmokers in all brain regions examined (average reduction, 28%). The mean λ k 3 values for the whole brain were 0.18 ± 0.04 and 0.13 ± 0.03 cc brain (ml plasma ) −1 min −1 for nonsmokers and smokers, respectively; P < 0.0003). Tranylcypromine treatment reduced λ k 3 by an average of 58% for the different brain regions. Our results show that tobacco smoke exposure is associated with a marked reduction in brain MAO A, and this reduction is about half of that produced by a brief treatment with tranylcypromine. This suggests that MAO A inhibition needs to be considered as a potential contributing variable in the high rate of smoking in depression and in the development of more effective strategies for smoking cessation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data
Patlak, C. S., Blasberg, R. G., & Fenstermacher, J. D. (1983) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1983.1 · Cited by 3,567
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
Smoking, smoking cessation, and major depression
Glassman, A. H. (1990) · JAMA · doi:10.1001/jama.1990.03450120058029 · Cited by 1,207
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073
Bach, A. W., Lan, N. C., Johnson, D. L., Abell, C. W., Bembenek, M. E., Kwan, S. W., Seeburg, P. H., & Shih, J. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4934 · Cited by 723
A radical hypothesis for neurodegeneration
Olanow, C. W. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90070-3 · Cited by 722
Inhibition of monoamine oxidase B in the brains of smokers
Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Shea, C., Schlyer, D., Wolf, A. P., et al. (1996) · Nature · doi:10.1038/379733a0 · Cited by 656
Self-citationProbability and Statistics for Engineers and Scientists.
Walpole, R. E., & Myers, R. H. (1978) · Biometrics · doi:10.2307/2530629 · Cited by 648
An Atlas of the Human Brain for Computerized Tomography.
(1978) · Annals of Internal Medicine · doi:10.7326/0003-4819-89-5-733_1 · Cited by 465
Nicotine Dependence and Major Depression: New Evidence From a Prospective Investigation
Breslau, N. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820130033006 · Cited by 443
Mapping Human Brain Monoamine Oxidase A and B with11C-Labeled Suicide Inactivators and PET
Fowler, J. S., MacGregor, R. R., Wolf, A. P., Arnett, C. D., Dewey, S. L., Schlyer, D., Christman, D., Logan, J., Smith, M., Sachs, H., et al. (1987) · Science · doi:10.1126/science.3099392 · Cited by 391
Self-citationCigarette smoking and protection from Parkinson's disease: False association or etiologic clue?
Morens, D. M., Grandinetti, A., Reed, D., White, L. R., & Ross, G. W. (1995) · Neurology · doi:10.1212/wnl.45.6.1041 · Cited by 370
Koeppe, R. A., Holthoff, V. A., Frey, K. A., Kilbourn, M. R., & Kuhl, D. E. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.130 · Cited by 347
Involvement of tobacco in alcoholism and illicit drug use
HENNINGFIELD, J. E., CLAYTON, R., & POLLIN, W. (1990) · British Journal of Addiction · doi:10.1111/j.1360-0443.1990.tb03084.x · Cited by 237
Cigarette smoking: an epidemiological overview
Wald, N. J., & Hackshaw, A. K. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011530 · Cited by 236
Zeller, E. A., Barsky, J., & Berman, E. R. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70965-4 · Cited by 181
The functional role of monoamine oxidases A and B in the mammalian central nervous system
Berry, M. D., Juorio, A. V., & Paterson, I. A. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90081-7 · Cited by 180
Saura, J., Bleuel, Z., Ulrich, J., Mendelowitsch, A., Chen, K., Shih, J. C., Malherbe, P., Da Prada, M., & Richards, J. G. (1996) · Neuroscience · doi:10.1016/s0306-4522(96)83013-2 · Cited by 168
Fowler, J. S., Wang, G., Logan, J., Xie, S., Volkow, N. D., MacGregor, R. R., Schlyer, D. J., Pappas, N. R., Alexoff, D. L., & Patlak, C. S. (1995) · PubMed · Cited by 163
Self-citationGender differences in cerebral blood flow as a function of cognitive state with PET.
Esposito, G., Horn, J. D. V., Weinberger, D. R., & Berman, K. F. (1996) · PubMed · Cited by 163
Berlin, I., Saïd, S., Spreux-Varoquaux, O., Launay, J.-M., Olivares, R., Millet, V., Lecrubier, Y., & Puech, A. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90058-6 · Cited by 160
Monoamine oxidase A and B activities in heavy smokers
Berlin, I., Saïd, S., Spreux‐Varoquaux, O., Olivares, R., Launay, J., & Puech, A. J. (1995) · Biological Psychiatry · doi:10.1016/0006-3223(95)00084-4 · Cited by 146
TREATMENT OF PULMONARY TUBERCULOSIS WITH HYDRAZIDE DERIVATIVES OF ISONICOTINIC ACID
Selikoff, I. J. (1952) · JAMA · doi:10.1001/jama.1952.03680100015006 · Cited by 124
Irreversible inhibition of monoamine oxidase by some components of cigarette smoke
Yu, P. H., & Boulton, A. A. (1987) · Life Sciences · doi:10.1016/0024-3205(87)90446-2 · Cited by 122
Riederer, P. F., Konradi, C., Schay, V., Kienzl, E., Birkmayer, G. J. D., Danielczyk, W., Sofic, E., & Youdim, M. B. H. (1987) · PubMed · Cited by 112
Logan, J., Dewey, S. L., Wolf, A. P., Fowler, J. S., Brodie, J. D., ANGRIST, B. M., Volkow, N. D., & Gatley, S. J. (1991) · Synapse · doi:10.1002/syn.890090306 · Cited by 105
Self-citationMonoamine oxidase B (MAO B) inhibitor therapy in Parkinson's disease
Fowler, J. S., Volkow, N. D., Logan, J., Schlyer, D. J., MacGregor, R. R., Wang, G.-J., Wolf, A. P., Pappas, N. R., Alexoff, D., Shea, C. E., et al. (1993) · Neurology · doi:10.1212/wnl.43.10.1984 · Cited by 85
Self-citationBerlin, I., Zimmer, R., Hm, T., Payan, C., Hergueta, T., Robin, L., & Puech, A. J. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb05445.x · Cited by 81
Clinical Pharmacology of Monoamine Oxidase Inhibitors
McDaniel, K. D. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198606000-00001 · Cited by 70
MacGregor, R. R., Fowler, J. S., Wolf, A. P., Halldin, C., & Långström, B. (1988) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.2580250102 · Cited by 67
Self-citationMacGregor, R. R., Halldin, C., Fowler, J. S., Wolf, A. P., Arnett, C. D., Långström, B., & Alexoff, D. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90173-x · Cited by 67
Self-citationDopamine Oxidation and Its Inhibition by (—)-Deprenyl in Man
Glover, V. A. S., Elsworth, J. D., & Sandler, M. (1980) · Springer eBooks · doi:10.1007/978-3-7091-8582-7_18 · Cited by 55
Carr, L. A., & Basham, J. K. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90455-k · Cited by 50
BIOGENIC AMINE ADDUCTS, MONOAMINE OXIDASE INHIBITORS, AND SMOKING
Boulton, A. A. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90308-x · Cited by 25
Clinical and biochemical aspects of depressive disorders: III. Treatment and controversies
Caldecott-Hazard, S., & Schneider, L. S. S. (1992) · Synapse · doi:10.1002/syn.890100209 · Cited by 24
Celada, P., Bel, N., & Artigas, F. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9324-2_47 · Cited by 16
Cited by
Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956
The therapeutic potential of monoamine oxidase inhibitors
Youdim, M. B. H., Edmondson, D., & Tipton, K. F. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1883 · Cited by 1,363
Ametamey, S. M., Honer, M., & Schubiger, P. A. (2008) · Chemical Reviews · doi:10.1021/cr0782426 · Cited by 1,271
MONOAMINE OXIDASE: From Genes to Behavior
Shih, J. C., Chen, K., & Ridd, M. J. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.197 · Cited by 1,206
Smoking, stress, and negative affect: Correlation, causation, and context across stages of smoking.
Kassel, J. D., Stroud, L. R., & Paronis, C. A. (2003) · Psychological Bulletin · doi:10.1037/0033-2909.129.2.270 · Cited by 1,080
Metadata
- Authors
- Fowler, J. S., Volkow, N. D., Wang, G.-J., Pappas, N., Logan, J., Shea, C., Alexoff, D., MacGregor, R. R., Schlyer, D. J., Zezulkova, I., & Wolf, A. P.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1996-11-26
- Volume
- 93
- Issue
- 24
- Pages
- 14065-14069
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2153455171
- Cited by
- 423
- References
- 37
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.